Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.

NCT05712746 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05712746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.
Lead sponsor
Otsuka Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
March 3, 2023
Completion date
May 31, 2027
Enrollment
1,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure